Biological and Clinical Attributes of Sporothrix globosa, a Causative Agent of Sporotrichosis

Abstract

Nallely Nava-Pérez, Lisset G Neri-García, Oscar E Romero-González, Joshua A Terrones-Cruz, Laura C García-Carnero,* Héctor M Mora-Montes* Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Guanajuato, 36050, Gto., México*These authors contributed equally to this workCorrespondence: Laura C García-Carnero; Héctor M Mora-Montes, Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, C.P, Guanajuato, 36050, Gto., México, Tel [phone] Ext. 8193, Fax [phone] Ext. 8153, Email [email protected]; [email protected]: Sporotrichosis is an important subcutaneous mycosis with high prevalence and threat to human and animal health worldwide. Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa are the main etiological agents of this disease; and even though many efforts have been made recently to understand the Sporothrix-host interaction, little is known about S. globosa, an underestimated species. This organism shows the lowest virulence among the members of the Sporothrix pathogenic clade and represents an important pathogenic agent due to its global distribution. Here, we offer a review with all the known information about S. globosa, including its genome and proteomic information, and compare it with S. schenckii and S. brasiliensis, to explain the differences observed among these species, in terms of virulence, the host immune response, and the antifungal sensitivity. Also, we provide the gene prediction of some S. globosa putative virulence factors.Keywords: antifungal drugs, fungal infection, host–fungus interplay, epidemiology, diagnosis, treatment

Keywords

• antifungal drugs
• fungal infection
• host-fungus interplay
• epidemiology
• diagnosis
• treatment